Cited by 4,326Obstructive Sleep Apnea ResearchSleep and related disordersChronic Obstructive Pulmonary Disease (COPD) Research

Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis

Open access
Benjafield, Adam V, Ayas, Najib T, Eastwood, Peter R, Heinzer, Raphael, Ip, Mary S M, Morrell, Mary J, Nunez, Carlos M, Patel, Sanjay R +7 more·2019·The Lancet Respiratory Medicine

Abstract

BACKGROUND: There is a scarcity of published data on the global prevalence of obstructive sleep apnoea, a disorder associated with major neurocognitive and cardiovascular sequelae. We used publicly available data and contacted key opinion leaders to estimate the global prevalence of obstructive sleep apnoea. METHODS: We searched PubMed and Embase to identify published studies reporting the prevalence of obstructive sleep apnoea based on objective testing methods. A conversion algorithm was created for studies that did not use the American Academy of Sleep Medicine (AASM) 2012 scoring criteria to identify obstructive sleep apnoea, allowing determination of an equivalent apnoea-hypopnoea index (AHI) for publications that used different criteria. The presence of symptoms was not specifically analysed because of scarce information about symptoms in the reference studies and population data. Prevalence estimates for obstructive sleep apnoea across studies using different diagnostic criteria were standardised with a newly developed algorithm. Countries without obstructive sleep apnoea prevalence data were matched to a similar country with available prevalence data; population similarity was based on the population body-mass index, race, and geographical proximity. The primary outcome was prevalence of obstructive sleep apnoea based on AASM 2012 diagnostic criteria in individuals aged 30-69 years (as this age group generally had available data in the published studies and related to information from the UN for all countries). FINDINGS: Reliable prevalence data for obstructive sleep apnoea were available for 16 countries, from 17 studies. Using AASM 2012 diagnostic criteria and AHI threshold values of five or more events per h and 15 or more events per h, we estimated that 936 million (95% CI 903-970) adults aged 30-69 years (men and women) have mild to severe obstructive sleep apnoea and 425 million (399-450) adults aged 30-69 years have moderate to severe obstructive sleep apnoea globally. The number of affected individuals was highest in China, followed by the USA, Brazil, and India. INTERPRETATION: To our knowledge, this is the first study to report global prevalence of obstructive sleep apnoea; with almost 1 billion people affected, and with prevalence exceeding 50% in some countries, effective diagnostic and treatment strategies are needed to minimise the negative health impacts and to maximise cost-effectiveness. FUNDING: ResMed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(19)30198-5

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • It has been estimated that nearly one billion people have OSA worldwide, of which the vast majority is undiagnosed.

    “Using rates of obesity, race/ethnicity data, age, and regional prevalence data, it has been estimated that nearly one billion people have OSA worldwide, of which the vast majority is undiagnosed.98”

    From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [98]

    The Results estimate 936 million adults aged 30–69 with OSA worldwide, and Methods > Data collection and analysis describes using BMI, race, age, and geographic proximity to estimate prevalence where country data were unavailable. The Introduction says most cases remain undiagnosed even in developed countries, but the paper does not estimate the undiagnosed share of the global total or establish that it is a vast majority. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Obstructive sleep apnea affects approximately 25% of adults in the US and similar amounts in other high-income countries, although estimates vary depending on its definition.

    “Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder that affects approximately 25% of adults in the US and similar amounts in other high-income countries, although estimates vary depending on its definition (Gottlieb & Punjabi, 2020;Benjafield et al., 2019).”

    From Effects of mindfulness meditation and Acceptance and commitment therapy in patients with obstructive sleep apnea with residual excessive sleepiness: A randomized controlled pilot study (2023) · cites this paper as Benjafield et al., 2019

    The Results report a high burden of obstructive sleep apnoea in the USA, and the Discussion says prevalence estimates depend on diagnostic scoring criteria. The passages do not substantiate approximately 25% prevalence in the USA or similar rates across other high-income countries; the paper’s stated estimates concern adults aged 30–69, not all adults. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • The high global prevalence of obstructive sleep apnea represents a challenge for diagnosis as the current gold standard diagnostic test is polysomnography in a sleep laboratory, which is labour intensive and expensive.

    “The high global prevalence of OSA (Benjafield et al., 2019) represents a challenge for diagnosis as the current “gold standard” diagnostic test is PSG in a sleep laboratory, which is labour intensive and expensive (Kapur et al., 2017).”

    From Obstructive sleep apnea: transition from pathophysiology to an integrative disease model (2022) · cites this paper as Benjafield et al., 2019

  • It was estimated that globally, 936 million men and women aged 30-69 years have at least mild OSA and 425 million have moderate-to-severe OSA.

    “It was estimated that, globally, 936 million men and women of the considered age group have at least mild OSA and 425 million have moderate‐to‐severe OSA.”

    From Obstructive sleep apnea: transition from pathophysiology to an integrative disease model (2022) · cites this paper as Benjafield et al., 2019

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 59 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Benjafield, A. V., Ayas, N. T., Eastwood, P. R., Heinzer, R., Ip, M. S. M., Morrell, M. J., Nunez, C. M., Patel, S. R., Penzel, T., Pépin, J.-L., Peppard, P. E., Sinha, S., Tufik, S., Valentine, K., & Malhotra, A.
Affiliations
  • ResMed (United States) (US)
  • University of British Columbia (CA)
  • The University of Western Australia (AU)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • Royal Brompton & Harefield NHS Foundation Trust (GB)
  • University of Pittsburgh (US)
  • Charité – Universitätsmedizin Berlin (DE)
  • Inserm (FR)
  • University of Wisconsin–Madison (US)
  • All India Institute of Medical Sciences (IN)
  • University of California San Diego (US)
Corresponding author
Malhotra, Atul
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2019-08
Volume
7
Issue
8
Pages
687-698
ISSN
2213-2600 (ISSN-L)
OpenAlex
W2959442417
Cited by
4,326
References
59
Citations by year
2026: 768 · 2025: 883 · 2024: 735 · 2023: 676 · 2022: 539 · 2021: 446 · 2020: 252 · 2019: 24 · 2014: 1
FWCI
37.04
Type
journal article
Language
en
Open access
Locations
  • The Lancet Respiratory Medicine (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion, other-oa)
  • Murdoch University Research Portal (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • IRIS (submittedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
Funders
  • Philips
  • Fondation Leenaards
  • GlaxoSmithKline
  • Pharmaceuticals Bayer
  • ResMed
  • American Thoracic Society
  • National Health and Medical Research Council (1042341)
  • American Sleep Medicine Foundation
  • Agence Nationale de la Recherche (ANR-12-TECS-0010, ANR-15-IDEX-02)
  • ResMed Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (3200B0-105993, 3200B0-118308, 33CS30-139468, 33CS30-148401, 33CSCO-122661)
Topics
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
obstructive sleep apnea, global prevalence, disease burden, apnea-hypopnea index, conversion algorithm, China, United States, Brazil, India, obesity, cardiovascular risk, neuropsychological outcomes, treatment cost-effectiveness
MeSH terms
Adult, Aged, Asia, Europe, Female, Humans, Male, Middle Aged, South America, United States, Prevalence, Cost of Illness, Sleep Apnea, Obstructive, Internationality, Australasia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review